TW286273B - - Google Patents

Info

Publication number
TW286273B
TW286273B TW083105534A TW83105534A TW286273B TW 286273 B TW286273 B TW 286273B TW 083105534 A TW083105534 A TW 083105534A TW 83105534 A TW83105534 A TW 83105534A TW 286273 B TW286273 B TW 286273B
Authority
TW
Taiwan
Prior art keywords
pct
core member
support means
sec
delivery
Prior art date
Application number
TW083105534A
Other languages
English (en)
Chinese (zh)
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of TW286273B publication Critical patent/TW286273B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Paper (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
  • Details Of Garments (AREA)
  • Particle Formation And Scattering Control In Inkjet Printers (AREA)
TW083105534A 1993-06-17 1994-06-15 TW286273B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi

Publications (1)

Publication Number Publication Date
TW286273B true TW286273B (cg-RX-API-DMAC7.html) 1996-09-21

Family

ID=8538154

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083105534A TW286273B (cg-RX-API-DMAC7.html) 1993-06-17 1994-06-15

Country Status (24)

Country Link
US (1) US5694947A (cg-RX-API-DMAC7.html)
EP (1) EP0703802B1 (cg-RX-API-DMAC7.html)
JP (1) JP3803714B2 (cg-RX-API-DMAC7.html)
KR (1) KR100312764B1 (cg-RX-API-DMAC7.html)
CN (1) CN1126574C (cg-RX-API-DMAC7.html)
AT (1) ATE177657T1 (cg-RX-API-DMAC7.html)
AU (1) AU674758B2 (cg-RX-API-DMAC7.html)
BR (1) BR9407118A (cg-RX-API-DMAC7.html)
CZ (1) CZ284989B6 (cg-RX-API-DMAC7.html)
DE (1) DE69417232T2 (cg-RX-API-DMAC7.html)
DK (1) DK0703802T3 (cg-RX-API-DMAC7.html)
EE (1) EE03202B1 (cg-RX-API-DMAC7.html)
ES (1) ES2130423T3 (cg-RX-API-DMAC7.html)
FI (1) FI95768C (cg-RX-API-DMAC7.html)
GR (1) GR3030565T3 (cg-RX-API-DMAC7.html)
HU (1) HU217950B (cg-RX-API-DMAC7.html)
LT (1) LT3455B (cg-RX-API-DMAC7.html)
LV (1) LV12452B (cg-RX-API-DMAC7.html)
MY (1) MY113965A (cg-RX-API-DMAC7.html)
NO (1) NO311498B1 (cg-RX-API-DMAC7.html)
PL (1) PL176664B1 (cg-RX-API-DMAC7.html)
RU (1) RU2121824C1 (cg-RX-API-DMAC7.html)
TW (1) TW286273B (cg-RX-API-DMAC7.html)
WO (1) WO1995000199A1 (cg-RX-API-DMAC7.html)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6394094B1 (en) * 1998-05-01 2002-05-28 Enhance Pharmaceuticals, Inc. Method for injection molding manufacture of controlled release devices
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
WO2005004837A1 (en) * 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
ATE495752T1 (de) 2005-07-19 2011-02-15 Population Council Inc Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten
MX2008012009A (es) * 2006-03-20 2008-10-03 Duramed Pharmaceuticals Inc Anillos intravaginales comprimidos y flexibles, metodos de elaboracion y utilizacion de los mismos y apaato de elaboracion de los mismos.
AU2007324588B2 (en) * 2006-11-20 2012-09-13 Intervet International B.V. Helically-shaped drug delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
CN101977651A (zh) * 2008-01-25 2011-02-16 犹他大学研究基金会 线性级释放聚合物
CA2713943C (en) 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI20095563L (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
CA2764063C (en) 2009-06-03 2019-05-14 Forsight Labs, Llc Anterior segment drug delivery
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2013029194A1 (es) 2011-08-26 2013-03-07 Universidad De Santiago De Chile Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer
GB201115592D0 (en) * 2011-09-09 2011-10-26 Vivosens Medical Gmbh Flexible ring pessary
ES2912370T3 (es) 2011-09-14 2022-05-25 Forsight Vision5 Inc Aparato para inserción ocular
CN103007427B (zh) * 2011-09-21 2016-01-20 上海市计划生育科学研究所 缓控释宫内释药器及其制备方法
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2641602A1 (en) 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
KR20150051234A (ko) 2012-09-03 2015-05-11 에쏘세아 파르밍 에쎄.아. 수생 생물종의 배향 및／또는 억제를 위한 저장조 케이지 침지 시스템
JP6298068B2 (ja) 2012-10-26 2018-03-20 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼に対する薬物徐放用眼科システム
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
KR20150139919A (ko) 2013-04-10 2015-12-14 쁘레글렘 에스아 자궁 섬유종의 치료에서 사용하기 위한 프로게스테론 수용체 조절제
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
FI3125964T3 (fi) * 2014-04-01 2024-10-25 Poly Med Inc Ehkäisymenetelmä ja siihen liittyvä -väline
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
EP3160442B1 (en) * 2014-06-26 2019-03-06 TARIS Biomedical LLC Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN110403565B (zh) * 2018-04-27 2022-02-11 西安交通大学医学院第一附属医院 一种胶囊内窥镜磁与麦芒仿生双驱动装置
CN109771124A (zh) * 2019-01-31 2019-05-21 山东省药学科学院 一种具有形状记忆功能的子宫托
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1264731A (en) * 1917-03-19 1918-04-30 Carl Willers Pneumatic die-cushion.
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3911911A (en) * 1969-06-16 1975-10-14 Reese Hospital Michael Anti-fertility device
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
GB1465684A (en) * 1973-07-27 1977-02-23 Emmett L Contraceptive device
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE2616064A1 (de) * 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
DE3175137D1 (en) * 1981-12-30 1986-09-18 Population Council Inc Method of making intrauterine devices
JPS5919151U (ja) * 1982-07-28 1984-02-06 ニツポ−株式会社 痔疾治療器
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4822161A (en) * 1988-01-19 1989-04-18 Jimmy Michael F Illuminating spectacle apparatus
JPH02185264A (ja) * 1988-12-16 1990-07-19 Ferring Bv 膀胱内又は尿管へ薬を送り込む方法及び装置
KR100236355B1 (ko) * 1990-03-16 2000-01-15 이데이 노부유끼 와이프 패턴의 발생장치
JP3186105B2 (ja) * 1991-07-26 2001-07-11 日本電気株式会社 半導体装置のテストモード設定・解除回路
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
EE03202B1 (et) 1999-08-16
KR960703024A (ko) 1996-06-19
LTIP1957A (en) 1995-01-31
BR9407118A (pt) 1996-09-03
AU674758B2 (en) 1997-01-09
WO1995000199A1 (en) 1995-01-05
FI95768B (fi) 1995-12-15
HU9503290D0 (en) 1996-01-29
DE69417232T2 (de) 1999-11-04
CZ320895A3 (en) 1996-07-17
RU2121824C1 (ru) 1998-11-20
DK0703802T3 (da) 1999-10-11
JPH08511240A (ja) 1996-11-26
AU6848194A (en) 1995-01-17
GR3030565T3 (en) 1999-10-29
MY113965A (en) 2002-07-31
PL176664B1 (pl) 1999-07-30
EP0703802B1 (en) 1999-03-17
US5694947A (en) 1997-12-09
LT3455B (en) 1995-10-25
ES2130423T3 (es) 1999-07-01
PL312193A1 (en) 1996-04-01
JP3803714B2 (ja) 2006-08-02
KR100312764B1 (ko) 2002-11-23
ATE177657T1 (de) 1999-04-15
NO955029L (no) 1995-12-12
NO311498B1 (no) 2001-12-03
CN1125403A (zh) 1996-06-26
CN1126574C (zh) 2003-11-05
FI932789L (fi) 1994-12-18
FI932789A0 (fi) 1993-06-17
NO955029D0 (no) 1995-12-12
LV12452A (lv) 2000-04-20
EP0703802A1 (en) 1996-04-03
FI95768C (fi) 1996-03-25
DE69417232D1 (de) 1999-04-22
HU217950B (hu) 2000-05-28
HUT74548A (en) 1997-01-28
CZ284989B6 (cs) 1999-04-14
LV12452B (en) 2000-09-20

Similar Documents

Publication Publication Date Title
TW286273B (cg-RX-API-DMAC7.html)
GR3024468T3 (en) Inhalation powder containing antistatic agent.
HUT71683A (en) Microparticle preparations made from biodegradable copolymers
GB9203037D0 (en) Contrast agents
EP0698393A4 (en) SOLUBILIZING AGENT AND EXTERNAL PREPARATION CONTAINING THE SAME
HU9500631D0 (en) Sealing member
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
GR3025868T3 (en) Support catalyst and use of same.
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
ZA937614B (en) Progestationally active 19,11-bridged 4-estrenes
GB9310400D0 (en) Curable compositions
EP0647654A3 (cg-RX-API-DMAC7.html)
CA2165282A1 (en) Intravaginal delivery system
WO1996024378A3 (en) Delivery of exogenous compounds
EP0634168A4 (cg-RX-API-DMAC7.html)
MX9701031A (es) Utilizacion de la selegilina para el tratamiento de enfermedades epilepticas.
ES2141044A1 (es) Terapia con oxibutinina.
GB9315411D0 (en) Active agent delivery
FR2696066B1 (fr) Procédé pour transmettre des messages, et unité fonctionnelle et installation s'y rapportant.
UA23119A (uk) Психотропhий засіб

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees